STOCK TITAN

Adagene Inc. (NASDAQ: ADAG) insider reports 2.39M shares, 5.1% stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Adagene Inc. Schedule 13G filing reports that Jorey Chernett beneficially owned 2,389,060 Ordinary shares as of the close of business on March 17, 2026, representing 5.1% of the class based on 58,914,087 Ordinary Shares outstanding as of June 30, 2025, per the issuer's prospectus.

The cover disclosure notes the CUSIP 005329107 is assigned to the issuer's ADSs quoted on NASDAQ under the symbol ADAG, and that each ADS represents one and one quarter Ordinary Share. The filing is a beneficial ownership report by the reporting person, signed on March 18, 2026.

Positive

  • None.

Negative

  • None.

Insights

Holder reports a single beneficial stake of 5.1%, a disclosure-level ownership

Adagene's filing shows a beneficial ownership position of 2,389,060 Ordinary shares held by the reporting person as of March 17, 2026. The percentage uses the issuer's stated outstanding share count of 58,914,087 as of June 30, 2025.

Such Schedule 13G disclosures inform governance and voting landscapes; subsequent filings could update percent ownership if outstanding share counts change or further acquisitions/dispositions occur. Corporate records and proxy disclosures will reflect any voting implications tied to this stake.

Filing is a routine beneficial ownership disclosure under Schedule 13G

The report identifies the filing person, address, citizenship, and exact share counts with sole voting and dispositive power of 2,389,060 shares. It also cites the prospectus figure for outstanding shares, anchoring the 5.1% calculation.

From a compliance view, the filing meets identification and signature elements. Any material change in holdings or control would require an amended filing consistent with federal disclosure rules; timing of such amendments is governed by Schedule 13G/13D provisions.






005329107

(CUSIP Number)
03/16/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Represents Ordinary Shares held by the Reporting Person. There is no CUSIP number assigned to the Ordinary Shares. CUSIP number 005329107 has been assigned to the ADSs of the Issuer, which are quoted on NASDAQ Stock Market under the symbol “ADAG.” Each ADS represents one and one quarter Ordinary Share.


SCHEDULE 13G



Chernett Jorey
Signature:/s/ Jorey Chernett
Name/Title:Jorey Chernett
Date:03/18/2026

FAQ

What stake does Jorey Chernett report in ADAG?

Jorey Chernett reports beneficial ownership of 2,389,060 Ordinary shares as of March 17, 2026, representing 5.1% of the outstanding Ordinary shares using the issuer's disclosed base.

How was the 5.1% ownership calculated for ADAG?

The percentage is calculated using 58,914,087 Ordinary Shares outstanding as of June 30, 2025, as stated in the issuer's prospectus; that outstanding count anchors the 5.1% figure.

Does the filing indicate voting or dispositive power for the reported shares?

Yes, the cover data shows the reporting person has sole voting power and sole dispositive power over 2,389,060 shares, as reflected in the filing's itemized cover-page fields.

Are the CUSIP and ADS conversion details included in the filing?

The filing notes CUSIP 005329107 is assigned to the issuer's ADSs on NASDAQ under ADAG, and states each ADS represents one and one quarter Ordinary Share.
Adagene Inc.

NASDAQ:ADAG

View ADAG Stock Overview

ADAG Rankings

ADAG Latest News

ADAG Latest SEC Filings

ADAG Stock Data

188.05M
39.82M
Biotechnology
Healthcare
Link
China
Suzhou